Stock UniverseDerived research view · source repositories remain read-only

Krystal Biotech, Inc. (KRYS)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
High
Selection Score
40.48
Global Rank
357
Market Cap
8.06B
Latest Close
301.00
RS Composite
9.78% · G#765

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
4.16%
3M
18.65%
6M
38.42%
1Y
127.98%
3Y
155.41%
5Y
361.37%
10Y
2728.95%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 260.98K · 30-day average: 286.25K · Max drawdown over stored range: -53.42%

Research Snapshot

Relative Strength vs SPX

RS Composite9.78%
20D RS0.81%
60D RS9.07%
120D RS14.98%
Global RS Rank765 · 77.20% percentile
Qualified+ RS Rank297 · 76.39% percentile
Group ScopeQualified+
Primary RS Rank90 · 80.35% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank34 / 701
Primary Percentile95.29
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-04417.30Mn/a178.64M225.03M7.48364.94M27.21M337.74M30Mn/a42.81%53.92%87.45%80.93%501.31Mn/a

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$7.4840.3x$13.8621.7x$11.2226.8x$12.1224.8x

Shares Diluted: 30M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0050.699290.515389.13
Revenue Growth (YoY)2700%2700%2700%473.019%33.945%
Gross Profit0047.605270.454366.081
Operating Income-69.875-121.296-97.117103.248161.295
Free Cash Flow-116.274-153.548-100.603119.182188.914
Free Cash Flow Per Share-5.238-6.023-3.6254.0076.307
EPS (Diluted) GAAP-3.134229-5.4909380.3936.84
EPS Growth2700%2700%2700%669.231%128.0%
EPS Non-GAAP
Gross Margin2700%2700%93.897%93.095%94.077%
Operating Margin2700%2700%-191.556%35.54%41.45%
Profit Margin2700%2700%21.563%30.69%52.638%
Free Cash Flow Margin2700%2700%-198.432%41.024%48.548%
Shares Outstanding (Diluted)22.196825.49227.75229.7429.951
Shares Change (YoY)18.149%14.845%8.866%7.163%0.709%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-04116.36Mn/a53.69M46.14%55.93M48.07%1.8330.51M501.31Mn/aprocessed
2025 Q42026-02-17107.11Mn/a44.27M41.33%51.40M47.99%1.7030.32M496.30Mn/aprocessed
2025 Q32025-11-0397.80Mn/a41.37M42.30%79.36M81.15%2.6629.83M392.60Mn/aprocessed
2025 Q22025-08-0496.04Mn/a39.31M40.93%38.33M39.91%1.2929.75M353.83Mn/aprocessed
2025 Q12025-05-0688.18Mn/a36.18M41.02%35.73M40.52%1.2029.87M308.77Mn/aprocessed
2024 Q42025-02-1991.14Mn/a41.38M45.40%45.48M49.90%1.5229.95M344.87Mn/aprocessed
2024 Q32024-11-0483.84Mn/a22.43M26.76%27.18M32.42%0.9129.90M373.97Mn/aprocessed
2024 Q22024-08-0570.28Mn/a8.57M12.19%15.57M22.15%0.5329.64M345.79Mn/aprocessed
2024 Q12024-05-0645.25Mn/a-6.68M-14.77%932.00K2.06%0.0329.29M359.01Mn/aprocessed
2023 Q42024-02-2642.14Mn/a3.14M7.45%8.69M20.63%0.3028.85M358.33Mn/aprocessed
2023 Q32023-11-068.56Mn/a-25.99M-3.04%80.75M9.44%2.7928.89M373.24Mn/aprocessed
2023 Q12023-08-07n/an/a-38.05Mn/a-33.21Mn/a-1.2526.66M275.88Mn/aprocessed
2023 Q12023-05-08n/an/a-48.82Mn/a-45.30Mn/a-1.7625.71M140.75Mn/aprocessed
2022 Q32022-11-07n/an/a-31.45Mn/a-29.85Mn/a-1.1725.62M186.41Mn/aprocessed
2022 Q22022-08-08n/an/a-28.75Mn/a-28.11Mn/a-1.1025.55M218.72Mn/aprocessed
2022 Q12022-05-09n/an/a-50.22Mn/a-49.97Mn/a-1.9925.11M269.30Mn/aprocessed
2021 Q42023-02-27n/an/a-98.80Mn/a-21.81Mn/a-0.6036.29M161.90Mn/aprocessed
2021 Q32021-11-08n/an/a-15.65Mn/a-15.59Mn/a-0.7022.21M286.61Mn/aprocessed
2021 Q22021-08-09n/an/a-16.39Mn/a-16.36Mn/a-0.7422.20M329.53Mn/aprocessed
2021 Q12021-05-10n/an/a-14.35Mn/a-15.81Mn/an/an/a402.17Mn/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.